Cedric Hermans: How Iis TFPI Inhibition Changing Haemophilia Care?
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn:
“How is TFPI inhibition changing haemophilia care?
Join us for the next HaemXcellence live webinar:
TFPI Inhibition in Haemophilia: From Data to Clinical Practice
13 October 2026 | 17:00–18:00 CET
Together with Prof. Yesim Dargaud and Prof. Lorenzo Alberio, I look forward to discussing how the science and clinical data behind TFPI inhibition can be translated into everyday haemophilia practice.
A practical and interactive discussion on where anti-TFPI therapy fits in our rapidly evolving haemophilia treatment landscape.
Registration via the QR code on the invitation below.
Looking forward to the discussion!”

Other posts featuring Cedric Hermans on Hemostasis Today.
-
Nov 9, 2026, 17:11Ken Kuang: Why Your Calves Are Called Your “Second Heart”?
-
Nov 9, 2026, 17:07Mert Dumantepe: Key Insights From The 8th Abu Dhabi International Vascular Conference
-
Nov 9, 2026, 16:57Amrita Sarkar: Exciting Advances in Hematology and Vascular Research at 54th Annual Philadelphia Workshop
-
Nov 9, 2026, 16:47Joey Boxer Samuels: Prolonged Sitting and Vein Thrombosis
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day